Navigation Links
LUMINEX CORPORATION TO HOST INVESTOR EVENT AT ASSOCIATION FOR MOLECULAR PATHOLOGY ANNUAL MEETING
Date:10/29/2013

AUSTIN, Texas, Oct. 29, 2013 /PRNewswire/ -- Luminex Corporation (NASDAQ: LMNX) announced today that management will host an investor event in Phoenix, Arizona at the Association for Molecular Pathology Annual Meeting on Wednesday, November 13, 2013 beginning at 5:30 pm Mountain time.

(Logo: http://photos.prnewswire.com/prnh/20100104/LUMINEXLOGO)

Patrick J. Balthrop, president and chief executive officer, and other members of the executive management team will provide insight into the company's long-term strategic plans, including a live demonstration of the Company's revolutionary sample-to-answer System, Project ARIES.

Advanced registration is required and attendance will be limited to those registered. To register, please contact Matthew Norman, Government and Investor Relations Manager.  Dinner will be served following the event.

The presentation will be webcast live and may be accessed at Luminex Corporation's website at http://www.luminexcorp.com.  Simply log on to the web at the address above, go to the Company section and access the Investor Relations link.  Please go to the website at least 15 minutes prior to the event to register, download and install any necessary audio/video software. If you are unable to participate during the live webcast, the presentation will be archived for six months on the website using the 'replay' link.

About Luminex Corporation
Luminex is committed to applying its passion for innovation toward advancing healthcare and research worldwide. The Company is transforming global healthcare and life-science research through the development, manufacturing and marketing of proprietary instruments and assays utilizing xMAP open-architecture, multi-analyte platform and MultiCode® real-time polymerase chain reaction (PCR) and multiplex PCR-based technologies, that deliver cost-effective and rapid results to clinicians and researchers. Luminex's technology is commercially available worldwide and in use in leading clinical laboratories as well as major pharmaceutical, diagnostic, biotechnology and life-science companies. The Company is meeting the needs of customers in markets as diverse as clinical diagnostics, pharmaceutical drug discovery, biomedical research including genomic and proteomic research, personalized medicine, bio-defense research and food safety. For further information on Luminex Corporation and the latest advances in multiplexing using award winning technology, please visit http://www.luminexcorp.com/.

Contacts:

Matthew Norman, 512.219.8020
Government and Investor Relations Manager
mnorman@luminexcorp.com

Harriss Currie, 512.219.8020
Sr. Vice President and CFO
hcurrie@luminexcorp.com


'/>"/>
SOURCE Luminex Corporation
Copyright©2012 PR Newswire.
All rights reserved

Related medicine technology :

1. Luminex Corporation Reports First Quarter 2012 Results
2. Luminex Corporation Announces Agreement to Acquire GenturaDx
3. Luminex Corporation Second Quarter Earnings Release Scheduled for July 30, 2012
4. Luminex Corporation Reports Second Quarter 2012 Results
5. Luminex Corporation and University Hospital of Wales Collaborate During Olympic Games
6. Luminex Corporation Awarded $11 Million Contract by Defense Threat Reduction Agency (DTRA)
7. Luminex Corporation Recognized as Best Technology Company in Austin
8. Luminex Corporation Hosts 10th Annual Planet xMAP Symposium in Monaco
9. Luminex Corporation To Present At Upcoming Investment Conferences In September
10. Luminex Corporation Reports Third Quarter 2012 Results
11. Luminex Corporation To Present At Leerink Swann Global Healthcare Conference
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:7/10/2019)... ... 10, 2019 , ... Physicians for Informed Consent (PIC) sent ... hundreds of its doctor and scientist members out of concern that some legislators, ... to vaccination and labeling them as “fraudulent.” , The letter explains how the ...
(Date:7/10/2019)... Ore. (PRWEB) , ... July 10, 2019 , ... ... from Ideaship, a patent leveraged venture capital firm that provides patent development capital ... to its disruptive rapid blood volume measurement technology. , “We recognize the technology ...
(Date:7/9/2019)... ORION, Mich. (PRWEB) , ... July 10, 2019 ... ... The specialists at Women’s Excellence fully understand Menopause and provide in-depth interpretation ... to develop a personalized menopausal management plan. , “We value your wants and ...
Breaking Medicine Technology:
(Date:7/9/2019)... ... July 10, 2019 , ... Women’s Excellence is pleased to offer a comprehensive ... a variety of topics including women’s health information, current events, advancements in healthcare technology, ... women’s healthcare and we’re excited to offer a new women’s health blog written by ...
(Date:7/9/2019)... ... July 09, 2019 , ... Human cytomegalovirus (HCMV) may not ... professor and chair in Veterinary Medicine at UMD, half of the population walking around ... body for the rest of your life and can flare up whenever your immune ...
(Date:7/9/2019)... ... July 09, 2019 , ... Complete Nutrition , a leading retailer offering ... brick-and-mortar only business toward an e-commerce company. With 15 years of experience in the ... demands of digital consumers. , As part of the transition, Complete Nutrition sold ...
(Date:7/9/2019)... ... July 09, 2019 , ... ... in medical marketing and communications. Covering everything from multinational holding companies to five-person ... landscape. , The 2019 version of the Agency 100 contains a full profile ...
(Date:7/9/2019)... ... July 09, 2019 , ... Anxiety help can often feel out ... or stigma. A new online therapy platform called Emote seeks to change ... have access through their mobile device, tablet or computer to highly qualified licensed therapists ...
Breaking Medicine News(10 mins):